News & Updates
Filter by Specialty:
Ivermectin not superior to placebo in mild COVID-19
13 Sep 2022
byStephen Padilla
Early treatment with single- or double-dose ivermectin is no better than placebo in avoiding progression to hospitalization and in improving symptoms in mild COVID-19, results of a study have shown.
Ivermectin not superior to placebo in mild COVID-19
13 Sep 2022Nirmatrelvir conferred protection in older adults during the Omicron outbreak
13 Sep 2022
byElaine Soliven
During the surge of the Omicron (B.1.1.529) variant, antiviral therapy with nirmatrelvir significantly reduced the rate of COVID-19-related hospitalization or death among patients aged ≥65 years, according to a recent study.